Artia Global Partners »

Palisade Bio shares owned by Artia Global Partners

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.7M 2.0M 2.35

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Palisade Bio

Commodore Capital
Point72 Asset Management
Octagon Capital Advisors
Eversept Partners
Franklin Resources
Stempoint Capital
Renaissance Technologies
Vivo Capital
Vanguard Group
ADAR1 Capital Management
Artia Global Partners
BlackRock
Geode Capital Management
Exome Asset Management
Platinum Investment Mangement

View all funds holding Palisade Bio